Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Fourteen novel arene Ru , and cyclopentadienyl (Cp ) Rh and Ir complexes containing an N,N'-chelated pyridylimino- or quinolylimino ligand functionalized with the antimalarial drug sulfadoxine have been synthesized and characterized, including three by X-ray crystallography. The rhodium and iridium complexes exhibited potent antiplasmodial activity with IC values of 0.10-2.0 μm in either all, or one of the three Plasmodium falciparum assays (3D7 chloroquine sensitive, Dd2 chloroquine resistant and NF54 sexual late stage gametocytes) but were only moderately active towards Trichomonas vaginalis. They were active in both the asexual blood stage and the sexual late stage gametocyte assays, whereas the clinical parent drug, sulfadoxine, was inactive. Five complexes were moderately active against Mycobacterium tuberculosis (IC <6.3 μm), while sulfadoxine showed no antitubercular activity. An increase in the size of both the Cp ligand and the aromatic imino substituent increased hydrophobicity, which resulted in an increase in antiplasmodial activity.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/chem.201801090 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A novel intron variant is associated with emerging pfdhps mutant haplotypes in West and Central African Plasmodium falciparum.
Int J Parasitol Drugs Drug Resist
August 2025
Department of Infection Biology, Faculty of Infectious and Tropical Diseases, LSHTM, United Kingdom.
Sulfadoxine-pyrimethamine plays a key role in Plasmodium falciparum chemoprevention across Africa, yet the protective efficacy of SP is undermined by mutations conferring resistance in the genes encoding dihydrofolate reductase (pfdhfr) and dihydropteroate synthase (pfdhps). The emergence and spread of the pfdhps 431V mutation suggests that this may confer resistance and be selected by drug use. Here, we report a non-coding mutation a548383t, which expands a di-nucleotide repeat in the first intron of pfpppk-dhps.
View Article and Find Full Text PDFArtemisinin partial resistance (ART-R) in , due to mutations in the Kelch13 (K13) propeller domain, is spreading across Africa. However, data from Central Africa remain sparse. This study performed molecular surveillance in a peri-urban sentinel site in Libreville, Gabon, from 2021 to 2023 to assess emerging resistance markers and parasite population dynamics.
View Article and Find Full Text PDFFrequencies of molecular markers of drug resistance in the context of two different Seasonal Malaria Chemoprevention (SMC) treatment regimens in the Koulikoro health district, Mali.
Antimicrob Agents Chemother
August 2025
University Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
With growing concern about parasite resistance to sulfadoxine-pyrimethamine (SP) in West Africa, the effectiveness of dihydroartemisinin-piperaquine (DHA + PQ) was assessed as an alternative drug regimen for Seasonal Malaria Chemoprevention (SMC). This study aims to determine the prevalence of molecular markers of resistance to SP + AQ and DHA + PQ in Koulikoro (Mali), where SMC has been implemented since 2014. -positive samples were analyzed by either next-generation sequencing, focusing on SNPs in genes known to be associated with resistance: and genes, and using qPCR for copy number variations (CNVs) of and .
View Article and Find Full Text PDF"We witnessed medicines help our children, then we became proud": experiences and acceptability of seasonal malaria chemoprevention in Aweil, South Sudan.
Malar J
August 2025
National Ministry of Health, Juba, South Sudan.
Background: Malaria remains a significant public health concern, particularly in resource-constrained settings and regions affected by ongoing humanitarian crises, such as Northen Bahr el Ghazal in South Sudan. For successful implementation and uptake of malaria interventions, it is important to understand community perceptions in these contexts. Therefore, we present the findings of the qualitative study examining the feasibility of implementing seasonal malaria chemoprevention (SMC) and acceptability of the intervention by the community in this complex setting.
View Article and Find Full Text PDFThe transmission blocking activity of artemisinin-combination, non-artemisinin, and 8-aminoquinoline antimalarial therapies: A pooled analysis of individual participant data.
PLoS Med
August 2025
Department of Medical Microbiology and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands.
Background: Interrupting human-to-mosquito transmission is important for malaria elimination strategies as it can reduce infection burden in communities and slow the spread of drug resistance. Antimalarial medications differ in their efficacy in clearing the transmission stages of Plasmodium falciparum (gametocytes) and in preventing mosquito infection. Here, we present a retrospective combined analysis of six trials conducted at the same study site with highly consistent methodologies that allows for a direct comparison of the gametocytocidal and transmission-blocking activities of 15 different antimalarial regimens or dosing schedules.
View Article and Find Full Text PDF